Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/02/2873983/0/en/SpringWorks-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Highlights-Recent-Business-Updates.html
https://www.globenewswire.com/news-release/2024/04/24/2868970/0/en/SpringWorks-Therapeutics-Announces-Abstracts-Accepted-for-Presentation-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/18/2865264/0/en/SpringWorks-Therapeutics-to-Report-First-Quarter-2024-Financial-Results-Thursday-May-2-2024.html
https://www.globenewswire.com//news-release/2024/03/04/2839366/0/en/SpringWorks-Therapeutics-Initiates-Rolling-Submission-of-New-Drug-Application-to-the-FDA-for-Mirdametinib-for-the-Treatment-of-Children-and-Adults-with-NF1-PN.html
https://ir.springworkstx.com/news-releases/news-release-details/springworks-therapeutics-announces-european-medicines-agency
https://www.globenewswire.com//news-release/2024/02/29/2837999/0/en/SpringWorks-Therapeutics-Announces-European-Medicines-Agency-Validation-for-Marketing-Authorization-Application-of-Nirogacestat-for-the-Treatment-of-Adults-with-Desmoid-Tumors.html
https://www.globenewswire.com//news-release/2024/02/27/2835801/0/en/SpringWorks-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Highlights-Recent-Business-Updates.html
https://www.globenewswire.com//news-release/2024/02/22/2833507/0/en/SpringWorks-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html
https://www.investorsobserver.com/news/stock-update/where-does-springworks-therapeutics-inc-swtx-stock-fall-in-the-biotechnology-field-after-it-has-gained-12-41-this-week
https://www.globenewswire.com/news-release/2024/01/31/2820973/0/en/SpringWorks-Therapeutics-to-Participate-in-the-Guggenheim-Healthcare-Talks-6th-Annual-Biotechnology-Conference.html